ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

SNG Synairgen Plc

4.675
0.155 (3.43%)
25 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Synairgen Plc LSE:SNG London Ordinary Share GB00B0381Z20 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.155 3.43% 4.675 4.35 5.00 - 25,623 16:35:16
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 0 -17.65M -0.0876 -0.52 9.1M
Synairgen Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker SNG. The last closing price for Synairgen was 4.52p. Over the last year, Synairgen shares have traded in a share price range of 3.65p to 10.62p.

Synairgen currently has 201,374,975 shares in issue. The market capitalisation of Synairgen is £9.10 million. Synairgen has a price to earnings ratio (PE ratio) of -0.52.

Synairgen Share Discussion Threads

Showing 4926 to 4946 of 99175 messages
Chat Pages: Latest  199  198  197  196  195  194  193  192  191  190  189  188  Older
DateSubjectAuthorDiscuss
23/4/2020
21:12
TVM Crookie V interesting:

This indicates it could be used outside hospitals in the trial:


Patients admitted to hospital due to the severity of their COVID-19 disease OR non-hospitalised patients from high-risk co-morbidity groups such as the >65-years of age, or those with hypertension, cardiovascular disease, diabetes or a chronic lung condition


This is interesting as it means that the trial is on patients newly diagnosed:

Principal exclusion criteria
1. > 24 hours after confirmation of SARS-CoV-2 infection

toffeeman
23/4/2020
21:09
Well I held these when nobody else wanted them, so the potential has never escaped my attention. However my concern is more over the protocols that are required etc, and we have politics involved in pharma and data analysis, that to me could end up in a car crash. Or pretty much has Been so far. How would you expect these to manage or ayou just binary, sell a chunk at 80p and hold?
l0ngterm
23/4/2020
20:55
Not sure if this has been posted before but has all granular details of the trial:

hxxps://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001023-14/GB

Interesting numbers as 400 is listed across 20 sites.

crookie3634
23/4/2020
20:54
->> L0ngterm

I strongly believe SNG001 is going to work. There is so much circumstantial evidence that is positive which leads me to think the risk reward is excellent.

Just IMHO and DYOR..

nobbygnome
23/4/2020
20:50
Watch today's interview with Richard!

He knows where this is going and so do I!

likya123
23/4/2020
20:48
NobbyI have never seen you so positive on any share . Either positive or negative, what is driving you here?
l0ngterm
23/4/2020
20:37
Nobby, “you’re the man” 👍🏼
makendon
23/4/2020
20:35
I emailed Jim Cramer from Sqawk on the Street on CNBC today extolling the virtues of SNG because they were talking about possible treatments, all American companies of course!
nobbygnome
23/4/2020
20:31
Synairgen are simply in the right place at the right time!

From lse board..

BloombergToday 20:29

They have just had an interview with Dr Joseph Weinstein basically just said that the world needs a treatment that's low pressure ventilation direct to the lungs!

Naturally Bloomberg have now received a very factual and informative email from me pointing them in the direction of SNG

likya123
23/4/2020
20:27
Don’t see the late trades ? No big ones. Wish there were !

Edit. Of the buy variety

peachie 74
23/4/2020
20:17
Bit of a positive difference here though.

SNG has already got successful 'form'. :o)

From the RNS:

______


Two Phase II clinical trials in asthma showed that inhaled SNG001 treatment activated antiviral pathways in the lung along with improving lung function in patients with a respiratory viral infection.


We have also shown that treatment with inhaled SNG001 reduced lung viral load and lung pathology in an in vivo swine flu driven model of viral pneumonia.


At the time of the MERS-CoV outbreak in 2013, Synairgen collaborated with the National Institutes of Health (NIH) in the US to show that SNG001 could protect against MERS-CoV infection of lung cells in vitro.

jev1
23/4/2020
19:40
Don't start....
waterloo01
23/4/2020
19:39
Like IMM....
nobbygnome
23/4/2020
19:36
PDT It's often the way with biotech. Built on hype, killed on data.
waterloo01
23/4/2020
19:05
FinnCap Short Interview with Richard Marsden, CEO, Synairgen
Apr 23, 2020

whites123
23/4/2020
18:41
University of Southampton are the lead investigators of the trial and I suspect they will have recruited the most
torreskid
23/4/2020
18:21
I think RM in the interview was ackowledging SNG001 may not be the only COVID drug but will hopefully be effective with/without others.
I s'pose we know that anyway, since the trial was clear that it was only being tested on particular inclusion criteria candidates, eg not in ICU /ventilated pt's etc

If it does what we hope......supplying this to vulnerable / early onset viral pulmonary infections now and in the future is a massive breakthrough ! And maybe frontline staff for their protection ??

141jaffa
23/4/2020
18:04
I think opinion is split..we'll soon know.
dovey21
23/4/2020
17:54
Gilead trial looks like it's not the great hope. That was the best hope in the markets to date so attention should shift back to other treatment options, aka SNG (and a few others)
waterloo01
23/4/2020
17:51
About 1m late reported trades - again.
;-)

wetdream
23/4/2020
17:29
In relation to asthma - when is the inhaler supposed to be used? will it only be used during severe asthma attacks or used regularly like salbutamol?
asif12
Chat Pages: Latest  199  198  197  196  195  194  193  192  191  190  189  188  Older

Your Recent History

Delayed Upgrade Clock